Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chung

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 28, 2022
Patient-Reported and Clinical Outcomes From 5-Fraction SBRT for Oligometastases: A Prospective Single-Institution StudyRebecca K S Wong, Zhihui Amy Liu, Aisling Barry, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
European Urology Open Science|August 2, 2021
Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological OutcomesYazan Qaoud, Piero Bettoli, Noelia Sanmamed-Salgado, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2024
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled TrialRachel M Glicksman, Srinivas Raman, Xiang Y Ye, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancerKhaled Ajib, Michael C Tjong, Guan Hee Tan, et al.
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
The Journal of Urology|June 9, 2026
Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors: ErratumAhmad Mousa, Julian Chavarriaga, Sanchit Kaushal, et al.
The Journal of Urology|November 10, 2025
Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell TumoursAhmad Mousa, Julian Chavarriaga, Sanchit Kaushal, et al.
European Urology Oncology|September 10, 2020
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell TumorGregory J Nason, Michael A S Jewett, Peter J Bostrom, et al.
Urology|February 1, 2020
Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the TestisGregory J Nason, Laura Donahoe, Marc de Perrot, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|July 28, 2022
Patient-Reported and Clinical Outcomes From 5-Fraction SBRT for Oligometastases: A Prospective Single-Institution StudyRebecca K S Wong, Zhihui Amy Liu, Aisling Barry, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapyHamid Raziee, Fabio Y Moraes, Jure Murgic, et al.
European Urology Open Science|August 2, 2021
Salvage Radiotherapy Following Partial Gland Ablation for Prostate Cancer: Functional and Oncological OutcomesYazan Qaoud, Piero Bettoli, Noelia Sanmamed-Salgado, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2024
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled TrialRachel M Glicksman, Srinivas Raman, Xiang Y Ye, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancerKhaled Ajib, Michael C Tjong, Guan Hee Tan, et al.
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
The Journal of Urology|June 9, 2026
Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors: ErratumAhmad Mousa, Julian Chavarriaga, Sanchit Kaushal, et al.
The Journal of Urology|November 10, 2025
Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell TumoursAhmad Mousa, Julian Chavarriaga, Sanchit Kaushal, et al.
European Urology Oncology|September 10, 2020
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell TumorGregory J Nason, Michael A S Jewett, Peter J Bostrom, et al.
Urology|February 1, 2020
Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the TestisGregory J Nason, Laura Donahoe, Marc de Perrot, et al.
Pageof 24